Overview

Carvedilol Post-intervention Long-term Administration in Large-scale Trial

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether beta-blocker therapy improves 6-year clinical outcomes in patients with ST-segment elevation acute myocardial infarction and preserved left ventricular ejection fraction after primary percutaneous coronary intervention.
Phase:
Phase 4
Details
Lead Sponsor:
Takeshi Morimoto
Treatments:
Carvedilol